Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von SpringheelJack 

Metlife Inc. diskutieren

Metlife Inc.

WKN: 934623 / Symbol: MET / Name: MetLife / Aktie / Versicherungen / Large Cap /

65,82 €
-1,28 %

Buy Metlife Inc.

Buy Metlife Inc.

Einschätzung Buy
Rendite (%) 29,54 %
Kursziel 65,78
Veränderung
Endet am 05.04.24

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Wells Fargo & Company from $84.00 to $72.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 27,21 %
Kursziel 67,89
Veränderung
Endet am 05.04.24

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Piper Sandler from $82.00 to $74.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 23,01 %
Kursziel 72,39
Veränderung
Endet am 13.04.24

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Morgan Stanley from $90.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 13,66 %
Kursziel 71,19
Veränderung
Endet am 03.08.24

MetLife, Inc. (NYSE: MET) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $78.00 price target on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 14,18 %
Kursziel 67,03
Veränderung
Endet am 04.08.24

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Royal Bank of Canada from $70.00 to $74.00. They now have an "outperform" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 17,73 %
Kursziel 75,85
Veränderung
Endet am 15.08.24

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Wells Fargo & Company from $82.00 to $83.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 16,12 %
Kursziel 72,65
Veränderung
Endet am 18.08.24

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Morgan Stanley from $78.00 to $79.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 15,33 %
Kursziel 77,61
Veränderung
Endet am 06.10.24

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at JPMorgan Chase & Co. from $85.00 to $82.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 15,59 %
Kursziel 65,29
Veränderung
Endet am 17.11.24

MetLife, Inc. (NYSE: MET) had its "overweight" rating re-affirmed by analysts at Barclays PLC. They now have a $71.00 price target on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 12,61 %
Kursziel 71,43
Veränderung
Endet am 07.12.24

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Keefe, Bruyette & Woods from $79.00 to $77.00. They now have an "outperform" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 5,13 %
Kursziel 73,03
Veränderung
Endet am 08.01.25

MetLife, Inc. (NYSE: MET) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $80.00 price target on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 4,84 %
Kursziel 79,51
Veränderung
Endet am 10.01.25

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at UBS Group AG from $84.00 to $87.00. They now have a "buy" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 8,23 %
Kursziel 76,33
Veränderung
Endet am 05.02.25

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at UBS Group AG from $87.00 to $82.00. They now have a "buy" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 7,32 %
Kursziel 77,17
Veränderung
Endet am 06.02.25

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Wells Fargo & Company from $85.00 to $83.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) -2,89 %
Kursziel 78,61
Veränderung
Endet am 05.04.25

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Piper Sandler from $74.00 to $85.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,16 %
Kursziel 81,05
Veränderung
Endet am 10.04.25

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Keefe, Bruyette & Woods from $82.00 to $87.00. They now have an "outperform" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) -0,41 %
Kursziel 80,27
Veränderung
Endet am 11.04.25

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Wells Fargo & Company from $83.00 to $86.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,35 %
Kursziel 77,11
Veränderung
Endet am 15.04.25

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Morgan Stanley from $80.00 to $82.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat